Willingness to pay for a Rift valley fever (RVF) vaccine among Kenyan cattle producers

被引:8
|
作者
Wanyoike, Francis [1 ]
Mtimet, Nadhem [1 ,2 ]
Bett, Bernard [1 ]
机构
[1] ILRI, POB 30709, Nairobi 00100, Kenya
[2] Univ Carthage, Ecole Super Agr Mograne, Tunis, Tunisia
关键词
Rift valley fever; Willingness to pay; Cattle; Vaccination; DELIVERY; DISTRICT; OUTBREAK;
D O I
10.1016/j.prevetmed.2019.104763
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
A double bounded contingent valuation (CV) model was used to assess the Willingness to Pay (WTP) for vaccination of cattle against RVF in a sample of 276 livestock producers in Murang'a, Laikipia and Kwale Counties. While the level of awareness about the disease was rather low, nearly all respondents expressed willingness to have their animals vaccinated against the disease. Average WTP was highest in Murang'a (mean = US$1.44) where farmers practice dairy farming using exotic breeds of cattle compared to Laikipia (mean = US$1.24), where both exotic dairy and local breeds of cattle together with their crosses are kept, and Kwale (mean = US $1.01) where local breeds are predominantly kept. These average levels of WTP were 17%-67% higher than the estimated cost incurred by government (US$0.86 per head of cattle) in the most recent vaccination campaign conducted during RVF outbreak. Surprisingly, WTP tended to be lower among producers with many heads of cattle probably because the large herds would translate to bigger total costs. The study recommended support for sensitization campaigns about RVF and its control measures. While the high average levels of WTP implies potential for commercialization of vaccination against RVF, there may be need for price differentiation by region to ensure that sufficiently high numbers of producers vaccinate their animals to prevent outbreaks.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Antibodies against Rift Valley Fever Virus in Cattle, Mozambique
    Lagerqvist, Nina
    Moiane, Belisario
    Mapaco, Lourenco
    Fafetine, Jose
    Vene, Sirkka
    Falk, Kerstin I.
    EMERGING INFECTIOUS DISEASES, 2013, 19 (07) : 1177 - 1179
  • [32] EXPERIMENTAL INFECTION OF CATTLE WITH PANTROPIC RIFT VALLEY FEVER VIRUS
    COACKLEY, W
    PINI, A
    GOSDEN, D
    RESEARCH IN VETERINARY SCIENCE, 1967, 8 (04) : 399 - &
  • [33] Rift Valley fever virus infections in Egyptian cattle and their prevention
    Mroz, C.
    Gwida, M.
    El-Ashker, M.
    Ziegler, U.
    Homeier-Bachmann, T.
    Eiden, M.
    Groschup, M. H.
    TRANSBOUNDARY AND EMERGING DISEASES, 2017, 64 (06) : 2049 - 2058
  • [34] The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation
    Borrego, Belen
    Alonso, Celia
    Moreno, Sandra
    de la Losa, Nuria
    Sanchez-Cordon, Pedro Jose
    Brun, Alejandro
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (08):
  • [35] An outbreak of Rift Valley fever among peri-urban dairy cattle in northern Tanzania
    de Glanville, William A.
    Allan, Kathryn J.
    Nyarobi, James M.
    Thomas, Kate M.
    Lankester, Felix
    Kibona, Tito J.
    Claxton, John R.
    Brennan, Benjamin
    Carter, Ryan W.
    Crump, John A.
    Halliday, Jo E. B.
    Ladbury, Georgia
    Mmbaga, Blandina T.
    Mramba, Furaha
    Nyasebwa, Obed M.
    Rubach, Matthew P.
    Rostal, Melinda K.
    Sanka, Paul
    Swai, Emmanuel S.
    Szemiel, Agnieszka M.
    Willett, Brian J.
    Cleaveland, Sarah
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2022, 116 (11) : 1082 - 1090
  • [36] Farmers' preference and willingness to pay for a multivalent lumpy skin disease and Rift Valley fever novel vaccine: A discrete choice experiment in the Free State province, South Africa
    Masemola, Mampe
    Owusu-Sekyere, Enoch
    Ogundeji, Abiodun A.
    van Niekerk, Hermias N.
    Chaminuka, Petronella
    PREVENTIVE VETERINARY MEDICINE, 2021, 189
  • [37] Towards a safe, effective vaccine for Rift Valley fever virus
    LaBeaud, Desiree
    FUTURE VIROLOGY, 2010, 5 (06) : 675 - 678
  • [38] One Health approach to Rift Valley fever vaccine development
    Kortekaas, Jeroen
    ANTIVIRAL RESEARCH, 2014, 106 : 24 - 32
  • [39] A protective bivalent vaccine against Rift Valley fever and bluetongue
    Eva Calvo-Pinilla
    Alejandro Marín-López
    Sandra Moreno
    Gema Lorenzo
    Sergio Utrilla-Trigo
    Luis Jiménez-Cabello
    Julio Benavides
    Aitor Nogales
    Rafael Blasco
    Alejandro Brun
    Javier Ortego
    npj Vaccines, 5
  • [40] A protective bivalent vaccine against Rift Valley fever and bluetongue
    Calvo-Pinilla, Eva
    Marin-Lopez, Alejandro
    Moreno, Sandra
    Lorenzo, Gema
    Utrilla-Trigo, Sergio
    Jimenez-Cabello, Luis
    Benavides, Julio
    Nogales, Aitor
    Blasco, Rafael
    Brun, Alejandro
    Ortego, Javier
    NPJ VACCINES, 2020, 5 (01)